Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, previously known as OMP-131R10, is a novel monoclonal immunoglobulin engineered to target granulocyte-macrophage colony-stimulating GM-CSF. Its mode of action https://keiranihld492254.mpeblog.com/74500538/text